SearchBox:

Search Term: " Cannabichromene "

  Messages 1-2 from 2 matching the search criteria.
CV Sciences, Inc. Announces Landmark Publication on the Toxicology and Safety Assessment of ... VitaNet, LLC Staff 8/9/18
Medicinal Value of Cannabichromene (CBC) Darrell Miller 4/30/17




CV Sciences, Inc. Announces Landmark Publication on the Toxicology and Safety Assessment of ...
TopPreviousNext

Date: August 09, 2018 09:53 AM
Author: VitaNet, LLC Staff (support@vitanetonline.com)
Subject: CV Sciences, Inc. Announces Landmark Publication on the Toxicology and Safety Assessment of ...





CV Sciences, Inc. Announces Landmark Publication on the Toxicology and Safety Assessment of ...

The scientific study of the analysis of CBD oil got a major push recently. It's been almost 40 years since the last thorough toxicological safety assessment was run on a CBD oil. However, recently CV sciences had AIBMR Life Sciences Inc. perform a complete array of toxicological studies on Plus CBD oil, the company's consumer-lauded hemp cannabidiol oil. The study attested to the safety of oral consumption of the product.

The study conclusions, which have been shared in a peer-reviewed journal, attest to the fact that the oil was discovered to be non-clastogenic, non-mutagenic and non-genotoxic. A spokesperson for CV Sciences noted that the company was "thrilled" and would encourage all CBD companies to allow such studies to be conducted for their own base materials.

Key Takeaways:

  • CV Sciences Inc hired AIBMR Lifesciences Inc. to perform a full toxicological screening of CV's consumer-lauded CBD oil, specifically an extract from the base raw materials comprising it.
  • A peer-reviewed journal has published the findings, which indicate that the extract tested is non-mutagenic, non-clastogenic and non-genotoxic.
  • A spokesperson for CV Sciences indicated that the company was "thrilled" and also urged other CBD companies to have their base materials tested too.

"The toxicological assessment is the first known published data of its kind since the 1980 Rosenkrantz et al.’s publication with respect to toxicology data on CBD, Cannabichromene and hashish oil."

Read more: http://markets.businessinsider.com/news/stocks/cv-sciences-inc-announces-landmark-publication-on-the-toxicology-and-safety-assessment-of-base-material-of-its-pluscbd-oil-products-1027104828

(https://vitanetonline.com:443/forums/Index.cfm?CFApp=1&Message_ID=5701)


Medicinal Value of Cannabichromene (CBC)
TopPreviousNext

Date: April 30, 2017 02:14 PM
Author: Darrell Miller (support@vitanetonline.com)
Subject: Medicinal Value of Cannabichromene (CBC)





A health fan blogger has written a feature touting the medicinal benefits of Cannabichromene (CBC). CBC is found in cannabis. The writer states that CBC relieves pain, reduces depression, fights bacterial and fungus infections, and can bring down levels of anxiety. It also acts an anti-inflammatory agent. The blogger backs up her statements with references to medical publications. The piece has a photo of the formula for CBC, plus a video about cannabis and its components.

[video mp4="//www.healthnutnews.com/medicinal-value-of-Cannabichromene-cbc/"]

Key Takeaways:

  • Cannabichromene (CDC) is a cannabinoid synthesized in the marijuana plant and its presence is less common than THC or CBD.
  • The chemical has been tested on laboratory mice and has been shown to have anti-inflammatory, anti-fungal, antibacterial and anti-tumor effects.
  • CDC is a cannabinoid often overlooked by patients when determining which medication to use, but can provide many benefits to them due to its effects and prolonged life in the body.

"Studies have shown it safely and effectively provides a variety of therapeutic benefits, including improving pain, reducing inflammation, relieving depression and anxiety and inhibiting fungus growth."

(https://vitanetonline.com:443/forums/Index.cfm?CFApp=1&Message_ID=4511)



VitaNet ® LLC. Discount Vitamin Store.